Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,101

A multi-gene expression signature in tumors is associated with aggressive disease and poor patient outcomes, and it has the potential to become a genetic cancer biomarker.

The human cell’s primary source of energy, the mitochondria plays an important role in the metabolism of cancer cells. In a study recently published in PLOS ONE, researchers from throughout the world, including Dario C. Altieri, M.D., president and chief executive officer, director of the Ellen and Ronald Caplan Cancer Center, and Robert and Penny Fox Distinguished Professor at The Wistar Institute, have identified a particular gene signature indicative of mitochondrial reprogramming in tumors that is associated with a poor patient outcome.

Read more | >

I want patients to know that we are making advances every day. There are treatments that can offer cures, and we plan to deliver more.

I encourage patients to talk with their physicians about innovative treatment options and consider participating in clinical trials so we can move the field forward. Together, we can unlock the promise of immunotherapy.

Padmanee Sharma, M.D., Ph.D., is professor of Genitourinary Medical Oncology and Immunology and director of scientific programs for the James P. Allison Institute.

Read more | >

University of Saskatchewan (USask) researchers have developed a new method of killing brain cancer cells while preserving the delicate tissue around it. The technique also has a remarkable side-benefit: making chemotherapy treatment of brain cancer suddenly possible.

The technique involves placing long needles through the skull and sending pulses of into a glioblastoma tumor—the pernicious variety of brain cancer that caused Tragically Hip frontman Gord Downie’s death.

“A safer and more effective cancer treatment may be clinically possible,” said Dr. Mike Moser (MD), USask College of Medicine general surgery researcher and co-author of a study published recently in the Journal of Biomechanical Engineering.

Read more | >

It’s time to go to bed for artificial neurons.

According to a recent study by the University of California, San Diego, neural networks can imitate the sleep patterns of the human brain in order to tackle catastrophic forgetting.

“The brain is very busy when we sleep, repeating what we have learned during the day,” said Maxim Bazhenov, Ph.D., professor of medicine and a sleep researcher at the University of California San Diego School of Medicine in the press release. “Sleep helps reorganize memories and presents them in the most efficient way.”

Sleep strengthens rational memory, the capacity to recall arbitrary or illogical associations between objects, people, or events, and guards against forgetting previous memories, according to research by Bazhenov and colleagues.

Read more | >

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development and production of vaccines, drugs for severe diseases, as well as alternative food proteins much faster and at significantly lower costs than today.

How genes are expressed is a process that is fundamental to the functionality of cells in all living organisms. Simply put, the in DNA is transcribed to the molecule messenger RNA (mRNA), which tells the cell’s factory which to produce and in which quantities.

Researchers have put a lot of effort into trying to control gene expression because, among other things, it can contribute to the development of protein-based drugs. A recent example is the mRNA vaccine against COVID-19, which instructed the body’s cells to produce the same protein found on the surface of the coronavirus.

Read more | >

ETH Zurich researchers have found that a set of proteins have different shapes in the spinal fluid of healthy individuals and Parkinson’s patients. These could be used in the future as a new type of biomarker for this disease.

Many human diseases can be detected and diagnosed using biomarkers in blood or other . Parkinson’s disease is different: to date, there is no such being used in the clinicto indicate this neurodegenerative disease.

A team led by ETH Zurich Professor Paola Picotti could now help to close this gap. In a study just published in the journal Nature Structural and Molecular Biology, the researchers present 76 proteins that might serve as biomarkers for the detection of Parkinson’s disease.

Read more | >

Receive a $600 discount off your Powerplate at:
https://getpowerplate.com/panacea.

Health, Healing and Happiness with Nathan Crane.

Download Your Free Ebook and Guided Meditation:
http://www.NathanCrane.com.

Cancer; The Integrative Perspective — Documentary Film.

Home New

The Health and Healing Club — Online Education Membership.
https://www.healthandhealingclub.com/

Read more | >

When Lady Meherbai Tata died of leukaemia on 18 June 1931, her husband, Sir Dorabji Tata, Jamsetji Tata’s son and a key figure of the Tata Group endowed the Lady Tata Memorial Trust with a corpus for research into leukaemia in memory of his wife. He set out to establish high-quality facilities for cancer treatment in India.

(Images above of Dr. Indraneel Mittra and a representational photo of middle-aged women.)

Out of this humanitarian commitment emerged the now well-renowned Tata Memorial Hospital, commissioned by the Sir Dorabji Tata Trust on 28 February 1941.

Read more | >